Pleural diseases related to metastatic malignancies

European Respiratory Journal

Volumn 10, Issue 8, 1997, Pages 1907-1913

  Sahn, S A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cancer; Lung cancer; Malignant effusion; Paramalignant effusion; Talc pleurodesis

Indexed keywords

BIOPSY; DIAGNOSTIC TEST; HUMAN; LUNG CANCER; LUNG METASTASIS; PATHOGENESIS; PLEURA DISEASE; PLEURA EFFUSION; PLEURA FLUID; PLEURODESIS; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY;

HUMANS; NEOPLASM METASTASIS; NEOPLASMS; PLEURAL EFFUSION; PROGNOSIS; RADIOGRAPHY, THORACIC;

EID: 0030816496     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10081907     Document Type: Review

References (50)

1. Sahn SA. Malignant pleural effusions. Semin Respir Med 1987; 9: 43-53.
2. Chernow B, Sahn SA. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med 1977; 63: 695-702.
3. Meyer PC. Metastatic carcinoma of the pleura. Thorax 1966; 21: 437-443.
4. Sahn SA, Good JT Jr. Pleural fluid pH in malignant effusions: diagnostic, prognostic, and therapeutic implications. Ann Intern Med 1988; 108: 345-349.
5. Decker DA, Dines DE, Payne WS, Bernatz PE, Pairolero PC. The significance of a cytologically negative pleural effusion in bronchogenic carcinoma. Chest 1978; 74: 640-642.
6. Hsu C. Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients. Diagn Cytopathol 1987; 3: 8-12.
7. Sears D, Hajdu SI. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol 1987; 31: 85-97.
8. Wang N-S. The preformed stomas connecting the pleural cavity and the lymphatics in the parietal pleura. Am Rev Respir Dis 1975; 111: 12-20.
9. Staub NC, Wiener-Kronish JP, Albertine KH. Transport through the pleura: physiology of normal liquid and solute exchange in the pleural space. In: Chretien J, Bignon J, Hirsch A, eds. The Pleura in Health and Disease. New York, Marcel Dekker, 1985; pp. 169-193.
10. Spriggs AI, Boddington MM. The Cytology of Effusions. 2nd edn. London, William Heinemann, 1968.
11. Yam LT. Diagnostic significance of lymphocytes in pleural effusions. Ann Intern Med 1967; 66: 972-982.
12. Domagala W, Emeson E, Kass LG. Distribution of T-lymphocytes and B-lymphocytes in peripheral blood and effusions in patients with cancer. J Natl Cancer Inst 1978; 61: 295-300.
13. Fentiman IS, Millis R, Sexton S, Hayward JL. A pleural effusion in breast cancer: a review of 105 cases. Cancer 1981; 47: 2087-2092.
14. Blank N, Castellino RA. The intrathoracic manifestations of the malignant lymphomas and leukemia. Semin Roentgenol 1980; 15: 227-245.
15. Castellino RA, Bellani PF, Gasparini M, Musumeci R. Radiographic findings in previously untreated children with non-Hodgkin's lymphoma. Radiology 1975; 117: 657-663.
16. Fisher AMH, Kendall B, Van Leuven BD. Hodgkin's disease: a radiologie survey. Clin Radiol 1962; 13: 115-127.
17. Jenkins PF, Ward MJ, Davies P, Fletcher J. Non-Hodgkin's lymphoma, chronic lymphatic leukemia, and the lung. Br J Dis Chest 1981; 75: 22-30.
18. Xaubet A, Diumenjo MC, Marin A, et al. Characteristics and prognostic value of pleural effusions in non-Hodgkin's lymphomas. Eur J Respir Dis 1985; 66: 135-140.
19. Wong RM, Grace WJ, Rottino A. Pleural effusions, ascites, pericardial effusions, and edema in Hodgkin's disease. Am J Med Sci 1963; 246: 678-682.
20. Sahn SA. The pleura: state of the art. Am Rev Respir Dis 1988; 138: 184-234.
21. Judson MA, Sahn MA. Pulmonary physiologic abnormalities caused by pleural disease. Semin Respir Med 1995; 16: 346-353.
22. Weick JK, Kiely JM, Harrison EG Jr, Carr DT, Scanlon PW. Pleural effusion in lymphoma. Cancer 1973; 31: 848-853.
23. Maher GG, Berger HW. Massive pleural effusion: malignant and nonmalignant causes in 46 patients. Am Rev Respir Dis 1972; 105: 458-460.
24. Rabin CB, Coleman NS. Bilateral pleural effusion and significance in association with a heart of normal size. J Mt Sinai Hasp 1957; 24: 45-53.
25. Adelman M, Albelda SM, Gottlieb J, Haponik EF. Diagnostic utility of pleural fluid eosinophilia. Am J Med 1984; 77: 915-920.
26. Clarkson B. Relationship between cell type, glucose concentration, and response to treatment in neoplastic effusions. Cancer 1964; 17: 914-928.
27. Light RW, MacGregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77: 507-513.
28. Good JT Jr, Taryle DA, Sahn SA. The pathogenesis of low glucose, low pH malignant effusions. Am Rev Respir Dis 1985; 131: 737-741.
29. Cramer MR, Saldana MJ, Cepero RJ, Pitchenik AE. High amylase levels in neoplasm-related pleural effusion. Ann Intern Med 1989; 110: 567-570.
30. Johnson WW. The malignant pleural effusion: a review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer 1985; 56: 905-909.
31. Prakash UBS, Reinman HM. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 1985; 60: 158-164.
32. Canto A, Rivas J, Saumench J, Morera R, Moya J. Points to consider when choosing a biopsy method in cases of pleurisy of unknown origin. Chest 1983; 84: 176-179.
33. Boutin C, Viallat JR, Cargnino P, Farisse P. Thoracoscopy in malignant pleural effusions. Am Rev Respir Dis 1981; 124: 588-592.
34. Rusch VW, Mountain C. Thoracoscopy under regional anesthesia for the diagnosis and management of pleural disease. Am J Surg 1987; 154: 274-278.
35. Roper WH, Waring JJ. Primary serofibrinous pleural effusion in military personnel. Am Rev Respir Dis 1955; 71: 616-634.
36. Waite RJ, Carbonneau RJ, Valikian JP, Emali CB, Pezzella AT, Nash G. Parietal pleural changes in empyema: appearances at CT. Radiology 1990; 175: 145-150.
37. Dewald G, Dines DE, Weiland LH, Gordon H. Usefulness of chromosome examination in the diagnosis of malignant pleural effusions. N Engl J Med 1976; 295: 1494-1500.
38. Martini N, Bains MS, Beattie EJ Jr. Indications for pleurectomy in malignant effusion. Cancer 1975; 35: 734-738.
39. Fry WA, Khandekar JD. Parietal pleurectomy for malignant pleural effusion. Ann Surg Oncol 1995; 2: 160-164.
40. Livingston RB, McCracken JD, Trauth CJ, Chen T. Isolated pleural effusion in small cell lung carcinoma: favorable prognosis. Chest 1982; 81: 208-211.
41. Levine MN, Young JE, Ryan ED, Newhouse MT. Pleural effusion in breast cancer: thoracoscopy for hormone receptor determination. Cancer 1986; 57: 324-327.
42. Bruneau R, Ruben P. The management of pleural effusions in chylothorax and lymphoma. Radiology 1965; 85: 1085-1092.
43. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for the treatment of malignant pleural effusions. Ann Intern Med 1994; 120: 56-64.
44. Kennedy L, Sahn SA. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 1994; 106: 1215-1222.
45. Sanchez-Armengol A, Rodriguez-Panadero F, Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Chest 1993; 104: 1482-1485.
46. Kennedy L, Vaughan LM, Steed LL, Sahn SA. Sterilization of talc for pleurodesis: available techniques, efficacy, and cost analysis. Chest 1995; 107: 1032-1034.
47. Brandstetter RD, Cohn RP. Hypoxemia after thoracentesis: a predictable and treatable condition. J Am Med Assoc 1959; 242: 1060-1061.
48. Brown NE, Zamal N, Aberman H. Changes in pulmonary mechanics and gas exchange following thoracentesis. Chest 1978; 75: 540-541.
49. Lorch DG, Gordon L, Wooten S, Cooper JF, Strange C, Sahn SA. The effect of patient positioning on the distribution of tetracycline in the pleural space during pleurodesis. Chest 1988; 93: 527-529.
50. Little AG, Ferguson MK, Golomb HM, Hoffman PC, Vogelzang NJ, Skinner DB. Pleuroperitoneal shunting for malignant pleural effusions. Cancer 1986; 58: 2740-2743.